Akèy › Leksemi biphenotipik egi › Oklahoma › Tulsa
Etid klinik pou Leksemi biphenotipik egi nan Tulsa, OK
3 etid pou Leksemi biphenotipik egi ap chèche patisipan nan sit nan ak bò kote Tulsa (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Ap rekriteFaz 3
- Saint Francis Children's Hospital, Tulsa
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
Ap rekriteFaz 2
- Saint Francis Children's Hospital, Tulsa
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Ap rekriteFaz 4
- Saint Francis Children's Hospital, Tulsa
Etid Leksemi biphenotipik egi nan lòt vil
- Seattle, WA15 etid
- Houston, TX11 etid
- New York City, NY10 etid
- Atlanta, GA9 etid
- Durham, NC8 etid
- Memphis, TN7 etid
- Chicago, IL7 etid
- Charlotte, NC6 etid
- Aurora, CO6 etid
- Baldwin Park, CA6 etid
- Portland, OR6 etid
- Los Angeles, CA6 etid
Lòt etid nan Tulsa
- Ensifizyans kadyak10 etid
- Sipwa6 etid
- Obèsite5 etid
- Melanom5 etid
- Akidan serebral iskemi5 etid
- BPCO4 etid
- Maladi Parkinson4 etid
- Stenoz valv aòt4 etid
- Kansè kol4 etid
- Kansè nan tete4 etid
- Kansè Poumon ki pa ti selil4 etid
- Kansè ovè4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.